PMID- 30837427 OWN - NLM STAT- MEDLINE DCOM- 20190422 LR - 20221207 IS - 1119-3077 (Print) VI - 22 IP - 3 DP - 2019 Mar TI - The relationship between plasma homocysteine levels and MTHFR gene variation, age, and sex in Northeast China. PG - 380-385 LID - 10.4103/njcp.njcp_291_18 [doi] AB - BACKGROUND: Hyperhomocysteinemia (HHcy) is the risk factor for cardiovascular disease and stroke. However, the impacts on the genetic variation of methylene tetrahydrofolate reductase (MTHFR) on plasma homocysteine levels in the Northeast Chinese population have not been studied. Therefore, this study was carried out to determine the relationship between HHcy and MTHFR gene variation, and whether it was influenced by age and sex of the population in Northeast China. MATERIALS AND METHODS: A total of 466 subjects were randomly enrolled in this study. According to the homocysteine levels (Hcy >/= 15 mumol/L) of the subjects, they were divided into hyperhomocysteine (HHcy = 206) and normal homocysteine (Hcy = 260). Polymerase chain reaction/high-resolution dissolution curve and homocysteine determination kit methods were used for genotype testing and homocysteine detection, respectively. RESULTS: High plasma homocysteine levels are associated with MTHFR 677T and 1298A [P < 0.00, odds ratio (confidence interval) = 1.842 (1.418-2.394) >1], which is related to increasing age (P(range) = 0.0005-0.0161), with the homocysteine levels of males higher than females (P < 0.0001). CONCLUSION: High plasma homocysteine levels were linked to the MTHFR gene mutation. In addition, plasma homocysteine levels increased significantly with age with male's homocysteine levels higher than that of females. FAU - Wang, F AU - Wang F AD - Department of Geriatric Medicine, The First Affiliated Hospital of Jiamusi University, Heilongjiang, People's Republic of China. FAU - Sui, X AU - Sui X AD - Department of Geriatric Medicine, The First Affiliated Hospital of Jiamusi University, Heilongjiang, People's Republic of China. FAU - Xu, N AU - Xu N AD - Department of Geriatric Medicine, The First Affiliated Hospital of Jiamusi University, Heilongjiang; Chinese Ministry of Health Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, People's Republic of China. FAU - Yang, J AU - Yang J AD - Department of Geriatric Medicine, The First Affiliated Hospital of Jiamusi University, Heilongjiang, People's Republic of China. FAU - Zhao, H AU - Zhao H AD - Department of Geriatric Medicine, The First Affiliated Hospital of Jiamusi University, Heilongjiang, People's Republic of China. FAU - Fei, X AU - Fei X AD - Department of Geriatric Medicine, The First Affiliated Hospital of Jiamusi University, Heilongjiang, People's Republic of China. FAU - Zhang, Z AU - Zhang Z AD - Department of Geriatric Medicine, The First Affiliated Hospital of Jiamusi University, Heilongjiang, People's Republic of China. FAU - Luo, Z AU - Luo Z AD - Department of Geriatric Medicine, The First Affiliated Hospital of Jiamusi University, Heilongjiang, People's Republic of China. FAU - Xin, Y AU - Xin Y AD - Department of Geriatric Medicine, The First Affiliated Hospital of Jiamusi University, Heilongjiang, People's Republic of China. FAU - Qin, B AU - Qin B AD - Chinese Ministry of Health Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, People's Republic of China. FAU - Zhao, X AU - Zhao X AD - Chinese Ministry of Health Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, People's Republic of China. FAU - Cao, S AU - Cao S AD - Chinese Ministry of Health Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, People's Republic of China. FAU - Zhang, Y AU - Zhang Y AD - Chinese Ministry of Health Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, People's Republic of China. FAU - Yang, Z AU - Yang Z AD - Chinese Ministry of Health Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, People's Republic of China. LA - eng PT - Journal Article PL - India TA - Niger J Clin Pract JT - Nigerian journal of clinical practice JID - 101150032 RN - 0LVT1QZ0BA (Homocysteine) RN - EC 1.5.1.20 (MTHFR protein, human) RN - EC 1.5.1.20 (Methylenetetrahydrofolate Reductase (NADPH2)) SB - IM MH - Adult MH - Age Factors MH - Aged MH - Asian People/*genetics MH - Cardiovascular Diseases/etiology MH - China MH - Female MH - Genetic Predisposition to Disease MH - Genotype MH - Homocysteine/*blood MH - Humans MH - Hyperhomocysteinemia/complications/*genetics MH - Male MH - Methylenetetrahydrofolate Reductase (NADPH2)/*genetics MH - Middle Aged MH - Odds Ratio MH - Polymerase Chain Reaction MH - *Polymorphism, Genetic MH - Risk Factors MH - Sex Factors MH - Stroke/etiology OTO - NOTNLM OT - Age OT - MTHFR gene OT - Northeast China OT - gender OT - homocysteine COIS- None EDAT- 2019/03/07 06:00 MHDA- 2019/04/23 06:00 CRDT- 2019/03/07 06:00 PHST- 2019/03/07 06:00 [entrez] PHST- 2019/03/07 06:00 [pubmed] PHST- 2019/04/23 06:00 [medline] AID - NigerJClinPract_2019_22_3_380_253447 [pii] AID - 10.4103/njcp.njcp_291_18 [doi] PST - ppublish SO - Niger J Clin Pract. 2019 Mar;22(3):380-385. doi: 10.4103/njcp.njcp_291_18.